BridgeMD
New treatment option for Psoriasis
Official title A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis
ClinicalTrials.gov ID: NCT07489885
What this study is testing
What is D-2570 Tablet?
D-2570 Tablet is an investigational medicine, being studied as a potential treatment for psoriasis.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- A Study looking at the safety and efficacy of D-2570 in Participants with Plaque Psoriasis
- Phase 2: a mid-size study of how well it works
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance. You may not know which one you got.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 70
You may be able to join if
- Participants with a diagnosis of plaque psoriasis with no significant flares of disease activity for at least 6 months before signing the informed...
- Participants have moderate to severe plaque psoriasis as defined by a total body surface area (BSA) ≥10%, a Psoriasis Area and Severity Index (PASI)...
- Within normal ranges of laboratory assessments
You likely can't join if
- Any comorbidities or past medical conditions as outlined in the protocol that would interfere with study assessments as deemed by the Investigator
The study team makes the final eligibility decision.
Where it's taking place
- Birmingham, Alabama, United States
- Phoenix, Arizona, United States
- Chula Vista, California, United States
- Fountain Valley, California, United States
- Fremont, California, United States
- Los Angeles, California, United States
- San Diego, California, United States
- Fort Lauderdale, Florida, United States
- Miramar, Florida, United States
- Ocala, Florida, United States
- Tampa, Florida, United States
- Sandy Springs, Georgia, United States
- Savannah, Georgia, United States
- Idaho Falls, Idaho, United States
- Clarksville, Indiana, United States
- Louisville, Kentucky, United States
- Mayfield Heights, Ohio, United States
- Philadelphia, Pennsylvania, United States
- San Antonio, Texas, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Birmingham, Alabama, United States; Phoenix, Arizona, United States; Chula Vista, California, United States; Fountain Valley, California, United States; Fremont, California, United States; Los Angeles, California, United States and 13 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.